logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug as main reason for asking treatment among new and all outpatient clients in 2005 [see all tables in this series...]

Part (i) Percentage amongst new clients with opioids as primary drug

CountryInjectSmoke/inhaleEat/drinkSniffOthersBase (known status)Status unknown
Bulgaria64.115.40.016.73.81561
Czech Republic77.811.68.12.00.51982
Denmark15.539.438.56.60.021332
Germany37.924.527.88.71.224241470
Ireland28.962.78.40.00.05368
Greece42.911.50.545.10.09102
Spain(1)12.675.54.45.12.35124115
France18.214.77.459.20.584195
Italy46.249.20.53.80.21612522
Cyprus65.230.40.04.30.0690
Latvia92.40.07.60.00.01313
Lithuania98.50.41.10.00.02700
Hungary60.214.817.77.30.03440
Malta69.121.50.09.40.01915
Netherlands(2)9.372.611.83.42.832190
Slovakia75.720.02.91.40.01400
Finland68.30.011.919.80.01011
Sweden11.87.676.51.72.51193
United Kingdom(3)37.248.810.31.22.6168982374
Total38.348.27.05.11.4451114223

Notes:

 Only countries where there are clients reported with opiates as primary drug are shown. 

 (1) Data refer to 2004. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 01.04.2004 and 31.03.2005. 

 See also 'Table TDI-110' for cocaine CIH and crack route of administration distribution, and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - TDI - outpatient treatment centres. 

Page last updated: Monday, 12 November 2007